MedPath

海南卓力制药有限公司

Ownership
-
Established
2018-11-28
Employees
-
Market Cap
-
Website
http://www.choilio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20247321
Approval Date
Dec 18, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20247319
Approval Date
Dec 16, 2024
NMPA

枫蓼肠胃康滴丸

Approval Number
国药准字Z20090448
Approval Date
Nov 22, 2023
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20234483
Approval Date
Nov 14, 2023
NMPA

三七冠心宁滴丸

Approval Number
国药准字Z20090684
Approval Date
Nov 1, 2023
NMPA

消癌平滴丸

Approval Number
国药准字Z20080590
Approval Date
Aug 11, 2023
NMPA

前列舒乐片

Approval Number
国药准字Z20080576
Approval Date
Jun 13, 2023
NMPA

肿节风滴丸

Approval Number
国药准字Z20080533
Approval Date
Jun 13, 2023
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20233199
Approval Date
Feb 21, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.